Cargando…

Poor Sleep in Patients with Multiple Sclerosis

BACKGROUND: Poor sleep is a frequent symptom in patients with multiple sclerosis (MS). Sleep may be influenced by MS-related symptoms and adverse effects from immunotherapy and symptomatic medications. We aimed to study the prevalence of poor sleep and the influence of socio-demographic and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bøe Lunde, Hanne Marie, Aae, Tommy F., Indrevåg, William, Aarseth, Jan, Bjorvatn, Bjørn, Myhr, Kjell-Morten, Bø, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498191/ https://www.ncbi.nlm.nih.gov/pubmed/23166808 http://dx.doi.org/10.1371/journal.pone.0049996

Ejemplares similares

Employment among Patients with Multiple Sclerosis-A Population Study
por: Bøe Lunde, Hanne Marie, et al.
Publicado: (2014)

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
por: Lunde, Hanne Marie Bøe, et al.
Publicado: (2017)

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study
por: Torgauten, Hilde Marie, et al.
Publicado: (2021)

Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood
por: Keshari, Pankaj K., et al.
Publicado: (2016)

Mortality and cause of death in multiple sclerosis in western Norway 1950–2021: a registry-based linkage study
por: Willumsen, Johannes Sverre, et al.
Publicado: (2022)

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway
por: Grytten, N, et al.
Publicado: (2016)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

The cost of multiple sclerosis in Norway
por: Svendsen, B., et al.
Publicado: (2010)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950–2018
por: Willumsen, Johannes Sverre, et al.
Publicado: (2020)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry
por: Benjaminsen, Espen, et al.
Publicado: (2019)

Deficient Phosphorylation of Stat1 in Leukocytes Identifies Neutralizing Antibodies in Multiple Sclerosis Patients Treated with Interferon-Beta
por: Gavasso, Sonia, et al.
Publicado: (2014)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Association of adverse childhood experiences with the development of multiple sclerosis
por: Eid, Karine, et al.
Publicado: (2022)

Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
por: Westerlind, Helga, et al.
Publicado: (2015)

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
por: Norborg, Hilde, et al.
Publicado: (2021)

Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles
por: Mero, Inger-Lise, et al.
Publicado: (2013)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
por: Eid, Karine, et al.
Publicado: (2021)

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis
por: Oveland, Eystein, et al.
Publicado: (2021)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
por: Riemer, Frank, et al.
Publicado: (2023)

The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2020)

CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
por: Bhan, Alok, et al.
Publicado: (2021)

Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
por: König, Marton, et al.
Publicado: (2023)

Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study
por: Nakken, Ola, et al.
Publicado: (2022)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016)

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
por: Bjørnevik, Kjetil, et al.
Publicado: (2016)

Fatigue in Multiple Sclerosis: A Look at the Role of Poor Sleep
por: Strober, Lauren B.
Publicado: (2015)

Poor sleep quality in patients with multiple sclerosis: gender differences
por: Vitkova, Marianna, et al.
Publicado: (2016)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
por: Jacobsen, Cecilie, et al.
Publicado: (2021)

Disease-modifying treatments for multiple sclerosis – a review of approved medications
por: Torkildsen, Ø, et al.
Publicado: (2016)

Fatigue Is Associated with Poor Sleep in People with Multiple Sclerosis and Cognitive Impairment
por: Cameron, Michelle H., et al.
Publicado: (2014)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
por: Mosleth, Ellen F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7eql9djim94h05fc0se8jpbir